Definition and research guide
This page combines a MeSH definition, publication statistics and selected research abstracts. It is a starting point for reading the literature, not a medical textbook or a systematic evidence review.
Content available: 4 complete abstracts (787 words), 10 references. Full article text is not stored or reproduced here; follow the PMID, DOI or PMC links to read the original sources and their access terms.
Definition
A structural polymer of the bacterial cell envelope consisting of sugars and amino acids which is responsible for both shape determination and cellular integrity under osmotic stress in virtually all bacteria.
Definition: NLM Medical Subject Headings (MeSH) scope note (Public domain (U.S. National Library of Medicine); attribution requested). View the MeSH record.
Also known as: Murein; Pseudomurein.
Where it fits in the MeSH classification
- Broader topics
- Glycopeptides; Mucoproteins; Polysaccharides, Bacterial
Research landscape
PubMed indexes 8,639 records tagged with the MeSH heading “Peptidoglycan” (counts retrieved 2026-10-31). 1,593 of them (18.4%) were published from 2020 onward, and the busiest period so far is 2010-2019 with 2,916 records.
Reviews account for 784 records (9.1%) and meta-analyses for 0. Randomized controlled trials number 4 (0.0%) as a share of all records on the topic. Randomized trials make up only a small share of this literature, so much of what is known comes from laboratory, observational or descriptive work.
Show the data
| Period | Records |
|---|---|
| through 1999 | 2,512 |
| 2000-2009 | 1,618 |
| 2010-2019 | 2,916 |
| 2020 onward | 1,593 |
Publication-type chart data
| Type | Records | Share |
|---|---|---|
| Reviews | 784 | 9.1% |
| Meta-analyses | 0 | 0.0% |
| Randomized controlled trials | 4 | 0.0% |
Method: PubMed query "Peptidoglycan"[MeSH Terms] with publication-type and date filters, retrieved 2026-10-31.
Reading the evidence in drugs and chemicals
Studies of a chemical or drug can answer very different questions: what it is and how it behaves in cells and animals, how the body handles it, and whether it changes outcomes in people. Laboratory and animal findings often do not carry over to patients, and observational studies of exposures are confounded by who uses a substance and why. Nothing on this page is a recommendation to use, avoid, start or stop any substance or medicine; talk to a qualified clinician or pharmacist about your own situation. Check the dose, the species, the comparison group and whether a patient-relevant outcome was measured.
Evidence from open-access studies
These open-access studies come from PubMed’s best-match results for this heading (papers whose main topic it is), ranked here by citation count, with one recent addition. Each abstract is reproduced in full under its recorded open licence so that you can read the authors’ own words. They illustrate the literature; they are not a systematic summary of it. Citation counts measure attention, not reliability or clinical benefit.
| Study / authors | Year | Source label / design | Europe PMC citations | Licence / source |
|---|---|---|---|---|
| Prophage-triggered membrane vesicle formation through peptidoglycan damage in Bacillus subtilis | 2017 | Research article Design not recorded in structured metadata | 283 | cc by PMID 28883390 · DOI · PMC5589764 |
| MreB filaments align along greatest principal membrane curvature to orient cell wall synthesis | 2018 | Research article Design not recorded in structured metadata | 181 | cc by PMID 29469806 · DOI · PMC5854468 |
| Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles' heel for the TB-causing pathogen | 2019 | Review article Design not recorded in structured metadata | 150 | cc by PMID 31183501 · DOI · PMC6736417 |
| Molecular interplay between peptidoglycan integrity and outer membrane asymmetry in maintaining cell envelope homeostasis | 2025 | Research article Design not recorded in structured metadata | 6 | cc by PMID 40965224 · DOI · PMC12548408 |
Prophage-triggered membrane vesicle formation through peptidoglycan damage in Bacillus subtilis [1]
Abstract reading summary — source excerpts
- Opening excerpt
- Bacteria release membrane vesicles (MVs) that play important roles in various biological processes.
- Closing excerpt
- show that a prophage-encoded endolysin can generate holes in the cell wall through which cytoplasmic membrane material protrudes and is released as vesicles.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (199 words)
Bacteria release membrane vesicles (MVs) that play important roles in various biological processes. However, the mechanisms of MV formation in Gram-positive bacteria are unclear, as these cells possess a single cytoplasmic membrane that is surrounded by a thick cell wall. Here we use live cell imaging and electron cryo-tomography to describe a mechanism for MV formation in Bacillus subtilis. We show that the expression of a prophage-encoded endolysin in a sub-population of cells generates holes in the peptidoglycan cell wall. Through these openings, cytoplasmic membrane material protrudes into the extracellular space and is released as MVs. Due to the loss of membrane integrity, the induced cells eventually die. The vesicle-producing cells induce MV formation in neighboring cells by the enzymatic action of the released endolysin. Our results support the idea that endolysins may be important for MV formation in bacteria, and this mechanism may potentially be useful for the production of MVs for applications in biomedicine and nanotechnology.It is unclear how Gram-positive bacteria, with a thick cell wall, can release membrane vesicles. Here, Toyofuku et al. show that a prophage-encoded endolysin can generate holes in the cell wall through which cytoplasmic membrane material protrudes and is released as vesicles.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 28883390 · DOI · PMC5589764
MreB filaments align along greatest principal membrane curvature to orient cell wall synthesis [2]
Abstract reading summary — source excerpts
- Opening excerpt
- MreB is essential for rod shape in many bacteria.
- Closing excerpt
- We propose that the coupling of MreB filament alignment to shape-reinforcing peptidoglycan synthesis creates a locally-acting, self-organizing mechanism allowing the rapid establishment and stable maintenance of emergent rod shape.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (146 words)
MreB is essential for rod shape in many bacteria. Membrane-associated MreB filaments move around the rod circumference, helping to insert cell wall in the radial direction to reinforce rod shape. To understand how oriented MreB motion arises, we altered the shape of Bacillus subtilis. MreB motion is isotropic in round cells, and orientation is restored when rod shape is externally imposed. Stationary filaments orient within protoplasts, and purified MreB tubulates liposomes in vitro, orienting within tubes. Together, this demonstrates MreB orients along the greatest principal membrane curvature, a conclusion supported with biophysical modeling. We observed that spherical cells regenerate into rods in a local, self-reinforcing manner: rapidly propagating rods emerge from small bulges, exhibiting oriented MreB motion. We propose that the coupling of MreB filament alignment to shape-reinforcing peptidoglycan synthesis creates a locally-acting, self-organizing mechanism allowing the rapid establishment and stable maintenance of emergent rod shape.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 29469806 · DOI · PMC5854468
Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles' heel for the TB-causing pathogen [3]
Abstract reading summary — source excerpts
- Opening excerpt
- Tuberculosis (TB), caused by the intracellular pathogen Mycobacterium tuberculosis, remains one of the leading causes of mortality across the world.
- Closing excerpt
- We also discuss known inhibitors of ATP-dependent Mur ligases, and discuss the potential for the development of pan-enzyme inhibitors targeting multiple Mur ligases.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (138 words)
Tuberculosis (TB), caused by the intracellular pathogen Mycobacterium tuberculosis, remains one of the leading causes of mortality across the world. There is an urgent requirement to build a robust arsenal of effective antimicrobials, targeting novel molecular mechanisms to overcome the challenges posed by the increase of antibiotic resistance in TB. Mycobacterium tuberculosis has a unique cell envelope structure and composition, containing a peptidoglycan layer that is essential for maintaining cellular integrity and for virulence. The enzymes involved in the biosynthesis, degradation, remodelling and recycling of peptidoglycan have resurfaced as attractive targets for anti-infective drug discovery. Here, we review the importance of peptidoglycan, including the structure, function and regulation of key enzymes involved in its metabolism. We also discuss known inhibitors of ATP-dependent Mur ligases, and discuss the potential for the development of pan-enzyme inhibitors targeting multiple Mur ligases.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 31183501 · DOI · PMC6736417
Molecular interplay between peptidoglycan integrity and outer membrane asymmetry in maintaining cell envelope homeostasis [4]
Abstract reading summary — source excerpts
- Opening excerpt
- The bacterial cell envelope is a critical interface with the environment, particularly in Gram-negative species where the outer membrane (OM) and peptidoglycan (PG) layers coordinate to maintain structural integrity and resist turgor.
- Closing excerpt
- These insights deepen our understanding of envelope coordination in Gram-negative bacteria.
- Interpretation limits
- Verbatim excerpts from the authors’ abstract; the closing excerpt may describe a finding, limitation or recommendation. Design, population, effect size and uncertainty have not been independently extracted or appraised. Read the complete abstract and linked paper before interpreting the findings.
Read complete abstract (304 words)
The bacterial cell envelope is a critical interface with the environment, particularly in Gram-negative species where the outer membrane (OM) and peptidoglycan (PG) layers coordinate to maintain structural integrity and resist turgor. Although this coordination is essential for survival, the molecular mechanisms linking OM and PG homeostasis remain poorly understood. LD-transpeptidases (LDTs) are enzymes that crosslink peptides in PG and incorporate d-amino acids, but their physiological roles are not fully defined. Here, we characterize the activity of the LDT enzyme LdtJ in Acinetobacter baumannii and investigate the consequences of its deletion. Loss of LdtJ disrupts cell morphology, downregulates PG precursor genes (e.g., dadA and alr), and activates the stringent response, including elevated ppGpp levels and dksA upregulation. These defects are fully suppressed in a ∆ldtJ ∆mla double mutant, implicating the OM lipid transport Mla pathway in compensatory regulation. RNA sequencing revealed that transcriptional changes in the ∆ldtJ mutant are reversed in the double mutant, highlighting a functional interplay between PG remodeling and OM lipid asymmetry. Our findings suggest that LdtJ contributes to envelope integrity not only through PG modification but also by influencing broader regulatory and metabolic networks.IMPORTANCEAcinetobacter baumannii is a leading cause of hospital-acquired infections and is highly resistant to antibiotics. Its survival relies on the integrity of the cell envelope, composed of the peptidoglycan (PG) layer and outer membrane (OM). While LD-transpeptidases are traditionally known for reinforcing PG structure through non-canonical crosslinking, our findings reveal that the LdtJ enzyme also plays a critical role in regulating cellular metabolism and stress responses. Deletion of ldtJ results in pronounced growth defects and abnormal cell morphology-phenotypes that are fully suppressed by disrupting the OM lipid asymmetry transport system, Mla. This genetic interaction uncovers a previously unrecognized link between PG remodeling and OM lipid homeostasis. These insights deepen our understanding of envelope coordination in Gram-negative bacteria.
Abstract reproduced from the open-access article under the recorded cc by licence; © the authors. PMID 40965224 · DOI · PMC12548408
Key reviews and meta-analyses
The most cited review-type papers among PubMed’s best-match results for this heading, listed with bibliographic details only. Follow the links for the full text and access terms.
- Research article Peptidoglycan types of bacterial cell walls and their taxonomic implications [5]
- Research article Peptidoglycan structure and architecture [6]
- Research article From the regulation of peptidoglycan synthesis to bacterial growth and morphology [7]
- Research article The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis [8]
- Research article Growth of the stress-bearing and shape-maintaining murein sacculus of Escherichia coli [9]
- Research article From bacterial killing to immune modulation: Recent insights into the functions of lysozyme [10]
References
- Toyofuku M, Cárcamo-Oyarce G, Yamamoto T, Eisenstein F, Hsiao CC, Kurosawa M, et al.. Prophage-triggered membrane vesicle formation through peptidoglycan damage in Bacillus subtilis. . 2017. PMID 28883390 · DOI · PMC5589764
- Hussain S, Wivagg CN, Szwedziak P, Wong F, Schaefer K, Izoré T, et al.. MreB filaments align along greatest principal membrane curvature to orient cell wall synthesis. . 2018. PMID 29469806 · DOI · PMC5854468
- Maitra A, Munshi T, Healy J, Martin LT, Vollmer W, Keep NH, et al.. Cell wall peptidoglycan in Mycobacterium tuberculosis: An Achilles' heel for the TB-causing pathogen. . 2019. PMID 31183501 · DOI · PMC6736417
- Nandy S, Tehrani AF, Hunt-Serracin AC, Biboy J, Pybus C, Vollmer W, et al.. Molecular interplay between peptidoglycan integrity and outer membrane asymmetry in maintaining cell envelope homeostasis. . 2025. PMID 40965224 · DOI · PMC12548408
- Schleifer KH, Kandler O. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol Rev. 1972. PMID 4568761 · DOI · PMC408328
- Vollmer W, Blanot D, de Pedro MA. Peptidoglycan structure and architecture. FEMS Microbiol Rev. 2008. PMID 18194336 · DOI
- Typas A, Banzhaf M, Gross CA, Vollmer W. From the regulation of peptidoglycan synthesis to bacterial growth and morphology. Nat Rev Microbiol. 2011. PMID 22203377 · DOI · PMC5433867
- Sauvage E, Kerff F, Terrak M, Ayala JA, Charlier P. The penicillin-binding proteins: structure and role in peptidoglycan biosynthesis. FEMS Microbiol Rev. 2008. PMID 18266856 · DOI
- Höltje JV. Growth of the stress-bearing and shape-maintaining murein sacculus of Escherichia coli. Microbiol Mol Biol Rev. 1998. PMID 9529891 · DOI · PMC98910
- Ragland SA, Criss AK. From bacterial killing to immune modulation: Recent insights into the functions of lysozyme. PLoS Pathog. 2017. PMID 28934357 · DOI · PMC5608400
About this article
- Sources
- NLM Medical Subject Headings (definition, synonyms); NCBI PubMed (counts, identifiers); Europe PMC (open-access abstracts and citation counts).
- Verification
- Every reference was resolved against PubMed on 2026-10-31; title, year and DOI matched.
- Review state
- automated source verified; no human expert review has been recorded yet.
- Version
- 1, last updated 2026-10-31.
See how EvidenceLib is built. Spotted an error? Email support@evidencehelix.com.
Evidence strength
EvidenceHelix's computed view of the study designs behind this topic: how common meta-analyses, randomized trials and reviews are, how recent the literature is, and a plain-language reading. It describes the design mix of the literature. It is not a quality appraisal of any study, and it is not medical advice.